AzTrials
AzTrials

Covid19CAPSNCT05037110

Physical Activity and Smell Trainings to Help Individuals With Coronavirus Disease (COVID-19) Recover From Persistent Smell and Taste Impairments - A Pilot Study

A study testing Physical activity and Smell training in people with Covid19, run by Université de Montréal at 1 site in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The primary objective of this study is to identify efficient treatments to help those with chemosensory losses due to Coronavirus disease (COVID-19). To do so, 75 participants, men and women, aged 18 years old and above living in Canada will be recruited. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Covid19
What is being tested?
Physical activity and Smell training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
75 participants
Where
1 siteCanada
Study dates
25 Oct 2021to Jun 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Be 18 years old and above
  • Have had COVID-19 diagnosed by laboratory tests
  • Have recovered from COVID-19
  • Have persistent problems with your sense of smell and/or taste due to COVID-19 in the past 3 months or more (priority to participants with only this complication)
  • Have access to a computer and internet connection and be able to download the Zoom application
  • Have access to a smart phone ("texting" and Bluetooth)
  • Live in Canada

Who cannot join

  • Do 150 minutes or more of physical activity that makes you out of breath every week
  • Have limitations related to a training aiming at improving the sense of smell
  • Have physical limitations that may limit physical activity
  • Be part of another study that may influence the current study

Trial locations and contacts

1 site in 1 country.

Marie-Eve Mathieu, PhD contact

514 343-6737

me.mathieu@umontreal.ca

Canada1 site, 1 recruiting
  • Université de Montréal

    Montreal, Quebec, H3C 3J7

    Marie-Eve Mathieu, 5143436737, me.mathieu@umontreal.ca

    Recruiting

Other trials in Canada

About this study

Official title: Physical Activity and Sensory Trainings to Help COVID-19 Patients Recover From Persistent Smell and Taste Impairments - A Pilot Study

The primary objective of this study is to identify efficient treatments to help those with chemosensory losses due to Coronavirus disease (COVID-19). To do so, 75 participants, men and women, aged 18 years old and above living in Canada will be recruited. Participants will be randomly assigned to one of the following three groups (25 in each group): physical activity, smell training, and control. Here is a quick summary of what participants in each group will have to do remotely during 12 weeks:

  • Physical activity group: Engage in physical activity for 12 weeks and wear a smart watch daily. Attend a 15-minute virtual meeting with a research professional every two weeks, that is six times during the 12 weeks.
  • Smell training group: Smell four odors twice a day for 12 weeks and evaluate their sensory perceptions via an online survey sent for each session specifically. Attend a 15-minute virtual meeting with a research professional every two weeks, that is six times during the 12 weeks.
  • Control group: Not change their usual routine for 12 weeks. Complete an online 15-minute follow-up questionnaire every two weeks, that is six times over the 12 weeks.

In addition, within each group, 10 individuals from Montreal, Quebec will be randomly selected to complete additional assessments in the laboratory. To distinguish this subgroup, it is called the "in-person subgroup." Participants will be assessed at the beginning of the intervention period, immediately after the intervention period, and 12 weeks after the end of the intervention period. The assessments include various questionnaires on sociodemographic data, physical and mental health, lifestyle habits, sensory dysfunction, nutritional preferences, as well as self-administered smell and taste tests sent by mail. The in-person subgroup only will have to do the following additional assessments: smell and taste tests using special equipment (olfactometer, gustometer, electroencephalogram) and online questionnaires on food intake for the day.

Conditions
Covid19
Being tested
Physical activity, Smell training
Keywords
Olfactory training, Physical activity, Chemosensory impairments, Persistent smell impairment
Medical subject headings
COVID-19, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Physical activityBehavioural

    For 12 weeks, do 150 minutes of moderate physical activity per week and wear a smart watch to monitor this physical activity goal. This is done remotely. Then, every two weeks, attend a remote individual meeting with a kinesiologist using a secured application (15 minutes each). Each online meeting will contain the following steps: 1) Review of health and activities recorded by the activity watch/app provided to the participant; 2) Discussion on how to reach/maintain the physical activity goal in the coming weeks according to individual health status, facilitators and barriers; 3) Elaboration of the next 2-week action plan.

  • Smell trainingOther

    For 12 weeks, morning and evening, smell four odors namely eucalyptol, phenyl ethanol, citronellal, and eugenol, for a total of five minutes per session. For each smell training session, complete a short, online survey regarding the pleasantness and intensity of the smell. This is done remotely. Then, every two weeks, attend a remote individual meeting with a research professional using secured application (15 minutes each). Each online meeting will contain the following steps: 1) Review of smell training; 2) Discussion on how to reach/maintain the training protocol in the coming weeks according to individual health status, facilitators and barriers; 3) Elaboration of the next 2-week action plan.

Study groups in NCT05037110
Study groupRoleWhat they receive
Physical activity groupExperimentalNot described
Receives: Behavioral: Physical activity
Chemosensory training groupExperimentalNot described
Receives: Other: Smell training
Control groupNo interventionFor 12 weeks, continue the participant's routine (no intervention). This is done remotely. Then, every two weeks, complete an online follow-up questionnaire (15 minutes each).

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes from baseline in olfactory score on the 40-item University of Pennsylvania Smell Identification Test (UPSIT) at week 14

    The UPSIT test is a validated self-administered test that assesses olfactory function. In this test, odorants are released when participants scratch the standardized odor-impregnated test booklet. After smelling the odor, participants identify the smell from a list of odorants. Possible scores range from 0 to 40, where a higher score means a higher olfactory function.

    Change = (Week 14 Score - Baseline Score)

    Measured: Baseline and Week 14

  2. Changes from Week 14 in olfactory score on the 40-item University of Pennsylvania Smell Identification Test (UPSIT) at Week 26.

    The UPSIT test is a validated self-administered test that assesses olfactory function. In this test, odorants are released when participants scratch the standardized odor-impregnated test booklet. After smelling the odor, participants identify the smell from a list of odorants. Possible scores range from 0 to 40, where a higher score means a higher olfactory function.

    Change = (Week 26 Score - Week 14 Score)

    Measured: Week 14 and Week 26

  3. Changes from Baseline in Gustatory Score on the 27-item Waterless Empirical Taste Test (WETT-SA) at Week 14

    The WETT-SA test is a validated self-administered test that assesses gustatory function. Participants rub each strip, one at a time, on their tongues in a circular fashion. Then, they have to indicate what they tasted from a provided list of answers. Participants' answers are compared to an answer key and a higher score means a higher gustatory function

    Change = (Week 14 Score - Baseline Score)

    Measured: Baseline and Week 14

  4. Changes from Week 14 in Gustatory Score on the 27-item Waterless Empirical Taste Test (WETT-SA) at Week 26

    The WETT-SA test is a validated self-administered test that assesses gustatory function. Participants rub each strip, one at a time, on their tongues in a circular fashion. Then, they have to indicate what they tasted from a provided list of answers. Participants' answers are compared to an answer key and a higher score means a higher gustatory function

    Change = (Week 26 Score - Week 14 Score)

    Measured: Week 14 and Week 26

  5. Changes from Baseline in Quality of Life on the 26-item World Health Organizations Quality of Life - Bref (WHOQoL-Bref) Questionnaire at Week 14

    This is a validated questionnaire that assesses the quality of life. Each item is rated on a 5-point Likert scale. The higher the score, the higher the quality of life of the individual.

    Change = (Week 14 Results - Baseline Results)

    Measured: Baseline and Week 14

  6. Changes from Week 14 in Quality of Life on the 26-item World Health Organizations Quality of Life - Bref (WHOQoL-Bref) Questionnaire at Week 26

    This is a validated questionnaire that assesses the quality of life. Each item is rated on a 5-point Likert scale. The higher the score, the higher the quality of life of the individual.

    Change = (Week 26 Results - Week 14 Results)

    Measured: Week 14 and Week 26

  7. Changes from Baseline in Food Preference on the Leeds Food Preference Questionnaire (LFPQ) at Week 14

    LFPQ is a validated software that assesses food preferences. Participants are presented with food items. Participants have to indicate "How pleasant would it be to experience a mouthful of this food now?". Then, they are presented with two food items, and they have to decide which of those items they would prefer to eat now.

    This questionnaire is filled by participants in the in-person subgroup only.

    Change = (Week 14 Results - Baseline Results)

    Measured: Baseline and Week 14

  8. Changes from Week 14 in Food Preference on the Leeds Food Preference Questionnaire (LFPQ) at Week 26

    LFPQ is a validated software that assesses food preferences. Participants are presented with food items. Participants have to indicate "How pleasant would it be to experience a mouthful of this food now?". Then, they are presented with two food items, and they have to decide which of those items they would prefer to eat now.

    This questionnaire is filled by participants in the in-person subgroup only.

    Change = (Week 26 Results - Week 14 Results)

    Measured: Week 14 and Week 26

  9. Changes from Baseline in Brain Responses Following Smell Stimulations at Week 14

    Brain responses to smell stimulations an olfactometer will be recorded by an electroencephalogram.

    • The olfactometer is a device that gently blows different odors into the participant's nose at specific time intervals.
    • The electroencephalogram is a non-invasive device that records the electrical activity of the participant's brain. Electrical sensors are placed on helmet-like equipment that the participant wears while he/she smells or tastes samples.

    The brain activity is measured; smell event-related potentials (latency, duration, and amplitude) using an electroencephalogram are obtained.

    This procedure is done by participants in the in-person subgroup only.

    Change = (Baseline Results - Week 14 Results)

    Measured: Baseline and Week 14

  10. Changes from Baseline in Brain Responses Following Taste Stimulations at Week 14

    Brain responses to taste stimulations using a gustometer will be recorded by an electroencephalogram.

    • The gustometer is a device that puts drops of different flavors on the participant's tongue at specific time intervals.
    • The electroencephalogram is a non-invasive device that records the electrical activity of the participant's brain. Electrical sensors are placed on helmet-like equipment that the participant wears while he/she smells or tastes samples.

    The brain activity is measured; taste event-related potentials (latency, duration, and amplitude) using an electroencephalogram are obtained.

    This procedure is done by participants in the in-person subgroup only.

    Change = (Baseline Results - Week 14 Results)

    Measured: Baseline and Week 14

  11. Changes from Week 14 in Brain Responses Following Smell Stimulations at Week 26

    Brain responses to smell stimulations using an olfactometer will be recorded by an electroencephalogram.

    • The olfactometer is a device that gently blows different odors into the participant's nose at specific time intervals.
    • The electroencephalogram is a non-invasive device that records the electrical activity of the participant's brain. Electrical sensors are placed on helmet-like equipment that the participant wears while he/she smells or tastes samples.

    The brain activity is measured; smell event-related potentials (latency, duration, and amplitude) using an electroencephalogram are obtained.

    This procedure is done by participants in the in-person subgroup only.

    Change = (Week 26 Results - Week 14 Results)

    Measured: Week 14 and Week 26

  12. Changes from Week 14 in Brain Responses Following Taste Stimulations at Week 26

    Brain responses to taste stimulations using a gustometer will be recorded by an electroencephalogram.

    • The gustometer is a device that puts drops of different flavors on the participant's tongue at specific time intervals.
    • The electroencephalogram is a non-invasive device that records the electrical activity of the participant's brain. Electrical sensors are placed on helmet-like equipment that the participant wears while he/she smells or tastes samples.

    The brain activity is measured; taste event-related potentials (latency, duration, and amplitude) using an electroencephalogram are obtained.

    This procedure is done by participants in the in-person subgroup only.

    Change = (Week 26 Results - Week 14 Results)

    Measured: Week 14 and Week 26

  13. Changes from Baseline in food intake on the four 24-hour dietary recall at Week 14

    Validated web-based 24-hour dietary recalls assess the food intake of the participant over the past 24 hours. Participant reports what they have eaten over 24-hours, meal by meal. They are presented with different portion sizes from which they have to select the one corresponding to each food item. This will be completed on four different days within the week following the laboratory visit. Then, calories and macronutrients are calculated.

    These questionnaires are filled by participants in the in-person subgroup only.

    Change = (Week 14 Results - Baseline Results)

    Measured: Baseline and Week 14

  14. Changes from Week 14 in food intake on the four 24-hour dietary recall at Week 26

    Validated web-based 24-hour dietary recalls assess the food intake of the participant over the past 24 hours. Participant reports what they have eaten over 24-hours, meal by meal. They are presented with different portion sizes from which they have to select the one corresponding to each food item. This will be completed on four different days within the week following the laboratory visit. Then, calories and macronutrients are calculated.

    These questionnaires are filled by participants in the in-person subgroup only.

    Change = (Week 26 Results - Week 14 Results)

    Measured: Week 14 and Week 26

Secondary outcomes (2)
  1. Change from Baseline in physical activity level on the International Physical Activity Questionnaire (IPAQ) at week 14

    IPAQ is a validated questionnaire. It assesses the physical activity level of participants over the past seven days. Based on the provided answer, a multiple of the estimated resting energy expenditure (METs) is calculated. Higher the METs value, the higher the physical activity level of the person.

    Change = (Week 14 Results - Baseline Results)

    Measured: Baseline and Week 14

  2. Change from Week 14 in physical activity level on the International Physical Activity Questionnaire (IPAQ) at week 26

    IPAQ is a validated questionnaire. It assesses the physical activity level of participants over the past seven days. Based on the provided answer, a multiple of the estimated resting energy expenditure (METs) is calculated. Higher the METs value, the higher the physical activity level of the person.

    Change = (Week 26 Results - Week 14 Results)

    Measured: Week 14 and Week 26

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Sep 2021
  2. Study start25 Oct 2021
  3. Primary completionJun 2023 (estimated)
  4. Study completionJun 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
75 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05037110
Sponsor's protocol ID
2021-374
Acronym
CAPS
Status last verified
Nov 2021
First submitted
2 Sep 2021
Last updated
17 Nov 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The analyses will be centralized in Dr. Mathieu's laboratory and collaborations are welcomed.

Questions about this trial

What is this clinical trial studying?

A study testing Physical activity and Smell training in people with Covid19, run by Université de Montréal at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 17 Nov 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Marie-Eve Mathieu, PhD (514 343-6737, me.mathieu@umontreal.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes from baseline in olfactory score on the 40-item University of Pennsylvania Smell Identification Test (UPSIT) at week 14 (time frame: Baseline and Week 14). The study lists 14 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Nov 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in